Fig 1.
CTPA illustration of RV/LV diameter ratio measurement: Measurement in this patient was 1.28.
Fig 2.
Flowchart of the study selection process.
Risk stratification according to RV/LV diameter ratio.
Table 1.
Demographic and clinical characteristics of acute pulmonary embolism patients in different RV/LV diameter ratio groups.
Table 2.
ICU admission and expired patients in each RV/LV diameter ratio groups.
Table 3.
Performance of RV/LV diameter >1, elevated NT-pro-BNP, RVD detection by Echo, and elevated troponin for predicting ICU admission.
Fig 3.
Composition of elevated and not elevated NT-pro-BNP patients in each RV/LV diameter ratio groups.
(P = 0.000).
Fig 4.
Composition of RVD detected by Echo and RVD not detected by Echo patients in each RV/LV diameter ratio groups.
(P< 0.001).
Fig 5.
Composition of RVD detected by Echo and RVD not detected by Echo patients in each RV/LV diameter ratio groups.
(P = 0.001).
Fig 6.
sPESI score distribution in each RV/LV diameter ratio groups.